- Open Access
Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?
© The Author(s) 2018
Received: 16 April 2018
Accepted: 16 April 2018
Published: 8 May 2018
The original article was published in Journal of Translational Medicine 2018 16:3
Correction to: J Transl Med (2018) 16:3 https://doi.org/10.1186/s12967-017-1378-2
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Zhao Y, Niu C, Cui J. Gamma-delta (γδ) T cells: friend or foe in cancer development? J Transl Med. 2018;16:3. https://doi.org/10.1186/s12967-017-1378-2.View ArticlePubMedPubMed CentralGoogle Scholar
- Van Acker HH, Anguille S, Van Tendeloo VF, Lion E. Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy. OncoImmunology. 2015;4(8):e1021538.View ArticlePubMedPubMed CentralGoogle Scholar